Clinical Trial Update: Dose-finding of Rivaroxaban in Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 dose-finding trial evaluating rivaroxaban in patients undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: AZ Sint-Jan AV | Conditions: Chronic Renal Failure | Phase 4 | Status: COMPLETED